Literature DB >> 1249478

Eosinophil kinetics in the hypereosinophilic syndrome.

D C Dale, R T Hubert, A Fauci.   

Abstract

The kinetics of 51-chromium-labeled eosinophils were studied in 6 patients with the idiopathic hypereosinophilic syndrome. The kinetics of these cells were compared with 51-chromium-labeled neutrophils of 9 normal subjects. The patient studies consistently showed that autologous labeled eosinophils transiently left the circulating cell pool in the first 3 hours after infusion, re-entered the circulating pool, and then disappeared from the circulation with a mean blood half-life of 44 +/- 2.0 hours. In contrast, the neutrophils of normal subjects left the circulation progressively with an estimated blood half-life of 12.4 +/- 2.0 hours. These data suggest that the leukocytosis of the hypereosinophilic syndrome may be due to the presence in the blood of an increased number of cells with a relatively long blood half-life.

Entities:  

Mesh:

Year:  1976        PMID: 1249478

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

Review 1.  Advances in diagnosis and treatment of eosinophilia.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

2.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy.

Authors:  C J Spry; P C Tai
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

Review 4.  The human eosinophil: roles in host defense and tissue injury.

Authors:  P F Weller; E J Goetzl
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

5.  Estimation of kinetic parameters of neutrophilic, eosinophilic, and basophilic granulocytes in human blood.

Authors:  K H Steinbach; P Schick; F Trepel; H Raffler; J Döhrmann; G Heilgeist; W Heltzel; K Li; W Past; J A van der Woerd-de Lange; H Theml; T M Fliedner; H Begemann
Journal:  Blut       Date:  1979-07

6.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

Authors:  L Prin; J Charon; M Capron; P Gosset; H Taelman; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.

Authors:  P Gosset; L Prin; M Capron; C Auriault; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

8.  The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung.

Authors:  C J Spry; A P Weetman; I Olsson; P C Tai; E G Olsen
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

9.  Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.

Authors:  W F Owen; M E Rothenberg; J Petersen; P F Weller; D Silberstein; A L Sheffer; R L Stevens; R J Soberman; K F Austen
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma.

Authors:  B Wang; L Yan; Z Yao; L K Roskos
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.